Surveying The Landscape Of Bispecific Antibodies In Clinical Development
This article was originally published in Pharmaceutical Approvals Monthly
Bispecific antibodies that can target two different disease antigens with one molecule come in many different formats and could be applied to a range of therapeutic areas. Oncology and inflammatory disease are at the forefront of clinical development (see related story, (Also see "Is The Time Finally Right For Bispecific Antibodies?" - Pink Sheet, 16 Apr, 2013.)).